Norinchukin Bank’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$213K Sell
10,903
-266
-2% -$5.28K ﹤0.01% 561
2026
Q1
$215K Sell
11,169
-242
-2% -$4.77K ﹤0.01% 554
2025
Q4
$216K Buy
11,411
+85
+0.8% +$1.57K ﹤0.01% 557
2025
Q3
$211K Sell
11,326
-14
-0.1% -$261 ﹤0.01% 555
2025
Q2
$209K Buy
11,340
+407
+4% +$7.22K ﹤0.01% 558
2025
Q1
$191K Buy
10,933
+476
+5% +$8.03K ﹤0.01% 555
2024
Q4
$181K Sell
10,457
-141
-1% -$2.58K ﹤0.01% 553
2024
Q3
$197K Buy
10,598
+15
+0.1% +$253 ﹤0.01% 548
2024
Q2
$163K Sell
10,583
-398
-4% -$5.69K ﹤0.01% 538
2024
Q1
$162K Sell
10,981
-120
-1% -$1.66K ﹤0.01% 545
2023
Q4
$158K Sell
11,101
-452
-4% -$6.42K ﹤0.01% 548
2023
Q3
$161K Buy
11,553
+725
+7% +$9.28K ﹤0.01% 536
2023
Q2
$127K Sell
10,828
-173
-2% -$1.97K ﹤0.01% 551
2023
Q1
$127K Buy
+11,001
New +$136K ﹤0.01% 554

Other funds holding SBRA

Norinchukin Bank's SBRA Position: Q2 2026 in Review

Norinchukin Bank reduced its Sabra Healthcare REIT (SBRA) stake by 2.4% in Q2 2026, selling an estimated $5.28K and leaving 10,903 shares worth $213K. The position accounts for ﹤0.01% of the portfolio, ranked #561.

Norinchukin Bank first reported a position in SBRA in Q1 2023 and has held it in 14 quarters since. The position peaked at $216K in Q4 2025. 464 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Norinchukin Bank held 10,903 shares of Sabra Healthcare REIT worth $213K as of Q2 2026.
  • Norinchukin Bank sold 266 Sabra Healthcare REIT shares in Q2 2026, an estimated $5.28K.
  • Sabra Healthcare REIT made up ﹤0.01% of Norinchukin Bank's portfolio in Q2 2026, its #561 holding.
  • Norinchukin Bank first reported a position in Sabra Healthcare REIT in Q1 2023 and has held it in 14 quarters since.
  • Norinchukin Bank's Sabra Healthcare REIT position peaked at $216K in Q4 2025.
  • 464 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Norinchukin Bank's 13F filing for Q2 2026, filed 14 Aug 2026.